913. Deputy Ken O'Flynn asked the Minister for Health which body holds ultimate responsibility for governance, validation, and publication of national data relating to suicidal ideation and self-harm presentations; and whether this responsibility is formally defined in policy. [32253/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
27,342 questions match, newest first.
914. Deputy Johnny Guirke asked the Minister for Health in relation to the free contraception scheme, the reason commonly used contraceptive medication such as elvina are still excluded; the steps being taken to ensure this scheme becomes genuinely inclusive of all available prescribed contraceptive pills; the processes in place to review and reconsider whether each type of pill is included for funding; and if she wi…
915. Deputy Peadar Tóibín asked the Minister for Health the number of protected disclosures that have gone missing or have been compromised that have been submitted to her Department or State bodies that are responsible to her Department. [32290/26]
916. Deputy Peadar Tóibín asked the Minister for Health the number of staff that have worked in the health service who have not been Garda vetted for that role. [32298/26]
917. Deputy Eamon Scanlon asked the Minister for Health the reason service users are charged a €4 daily charge when using HSE transport to day services in County Sligo; and if she will make a statement on the matter. [32318/26]
918. Deputy Ken O'Flynn asked the Minister for Health whether her Department receives any aggregated reporting on the number, status or utilisation of residential properties owned or managed by the HSE if not, whether she considers this a governance gap. [32321/26]
919. Deputy Ken O'Flynn asked the Minister for Health whether she has requested the establishment of a centralised national dataset on HSE residential property vacancy, duration, and disposal timelines; and if not, the reason for same. [32322/26]
920. Deputy Ken O'Flynn asked the Minister for Health the value-for-money or utilisation benchmarks applied at Department level in respect of vacant State-owned residential properties under the HSE. [32323/26]
921. Deputy Ken O'Flynn asked the Minister for Health whether she has received any assurance, audit, or certification that HSE-reported activity data, including counselling activity, is accurate, complete, and subject to standardised validation processes. [32324/26]
922. Deputy Ken O'Flynn asked the Minister for Health whether the risk of human error in HSE data systems has been quantified at national level; and whether any error thresholds or tolerances are defined. [32325/26]
923. Deputy Ken O'Flynn asked the Minister for Health whether her Department has assessed the consistency of data definitions and reporting standards across Health Regions. [32326/26]
924. Deputy Ken O'Flynn asked the Minister for Health whether she is informed of ambulance allocation or response delays exceeding defined thresholds, including delays exceeding 60 minutes. [32327/26]
925. Deputy Ken O'Flynn asked the Minister for Health whether ambulance dispatch timelines are formally linked to patient outcome monitoring or risk classification systems. [32328/26]
926. Deputy Ken O'Flynn asked the Minister for Health whether any national reporting framework exists for extreme ambulance delays and if such data is reported to her Department. [32329/26]
927. Deputy Ken O'Flynn asked the Minister for Health to clarify whether any non-statutory bodies receive funding indirectly through the HSE or other agencies under her remit, and to provide a full list including funding amounts. [32330/26]
928. Deputy Ken O'Flynn asked the Minister for Health the total expenditure by the HSE on externally procured home support services in each of the years 2022, 2023, 2024, 2025 and to date in 2026. [32332/26]
929. Deputy Ken O'Flynn asked the Minister for Health the total number of home support hours delivered by private providers in each of the years 2022-2026. [32333/26]
930. Deputy Ken O'Flynn asked the Minister for Health the proportion of total home support hours delivered by directly employed HSE staff, private providers and voluntary providers. [32334/26]
931. Deputy Ken O'Flynn asked the Minister for Health whether any value-for-money or cost comparison analysis has been conducted between directly employed home support workers and externally procured providers. [32335/26]
932. Deputy Ken O'Flynn asked the Minister for Health the average hourly cost to the HSE of directly employed home support staff compared with the €32.73 per hour paid to external providers. [32336/26]
933. Deputy Ken O'Flynn asked the Minister for Health whether the home support authorisation scheme includes any profit margin controls or cost transparency requirements for private providers. [32337/26]
934. Deputy Ken O'Flynn asked the Minister for Health whether her Department has conducted any updated economic modelling of the cost of overweight and obesity in Ireland since 2017; and if so, to provide the estimated annual cost to the public health service and the wider economy; and if she will make a statement on the matter. [32339/26]
935. Deputy Ken O'Flynn asked the Minister for Health whether her Department has produced projections for obesity prevalence in Ireland to 2030 and 2040; and if so, to provide those projections in tabular form; and if she will make a statement on the matter. [32340/26]
936. Deputy Ken O'Flynn asked the Minister for Health whether any modelling has been undertaken on the projected impact of overweight and obesity on acute hospital demand, primary care demand, and health service workforce requirements over the next 10 to 20 years; and if she will make a statement on the matter. [32341/26]
937. Deputy Ken O'Flynn asked the Minister for Health whether the Department has assessed the potential cost savings associated with expanded access to evidence-based obesity treatments, including pharmacological interventions; if so, to provide details of any such assessments; and if she will make a statement on the matter. [32342/26]